歐冠昇:中國於商品市場定價能力提升 相信本港經濟開始復甦
昨日(24日)起履新的港交所(00388.HK)新任行政總裁歐冠昇(Nicolas Aguzin)於倫敦商品交易所(LME)亞洲金屬研討會上表示,LME的中國會員相當重要,指中國在商品市場的定價能力提升。而港交所除了成立前海商品交易所(QME)外,亦已入股廣州期貨交易所,因此在岸及離岸、現貨及期貨,港交所亦有涉足。
他又指,隨著本港開始新型肺炎疫苗接種計劃,相信經濟將踏上復甦之路,本港亦一直為具有高度競爭力的國際金融中心。財經事務及庫務局局長許正宇表示,本港市場在疫情中表現仍穩健,首季集資市場表現強勁,按年增長九倍,亦錄得150億美元資金流入本港。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.